Intermittent Fasting
Time-restricted eating patterns that extend fasting periods to activate metabolic switches and longevity pathways.
Evidence Summary
Strong mechanistic evidence. Human trials show benefits for weight, metabolic health, and inflammatory markers. Various protocols studied (16:8, 5:2, etc.). UPDATE (August 2026): A systematic review of human nutritional interventions and cellular senescence (Ageing Research Reviews 2026; 29 articles, 27 trials, 3,811 participants) identified calorie restriction as producing the most recurrent reductions in circulating inflammatory and SASP-panel factors and in senescence-associated transcriptomic signatures - the strongest such signal of any nutritional strategy reviewed. Importantly, classical markers of senescent-cell abundance (CDKN2A/p16, CDKN1A/p21) and telomere length were largely unchanged or highly variable across the same trials. Fasting and CR therefore have the best human evidence for modulating the senescence-associated secretory environment, without established evidence of reducing senescent-cell burden itself. UPDATE (September 13, 2026): A peer-reviewed study in Cell (Grońska-Pęski, Acosta-Rodríguez et al., NYU/NIA, 9 Sep 2026) extends caloric restriction's effects to genome maintenance. Using high-fidelity duplex sequencing of bulk liver, bulk kidney, hepatocytes and cerebellar neurons, CR reduced genome-wide somatic mutation burden — both substitutions and indels — across tissues, and specifically lowered activity of SBS5, the clock-like mutational process responsible for most mammalian mutations. The reduction was largest in transcriptionally inactive regions, which argues against a simple transcription-coupled-repair explanation. This makes somatic mutation accumulation, long treated as an irreversible substrate of aging, look dose-responsive and diet-modifiable. Important boundaries: this is mouse CR, not human time-restricted eating; causality for lifespan is not demonstrated; and the finding does not transfer automatically to CR mimetics or to intermittent-fasting protocols, whose human evidence remains centred on metabolic and SASP-related markers. UPDATE (November 3, 2026): The largest human synthesis to date — a BMJ 2025 systematic review and network meta-analysis (Semnani-Azad et al.; 99 randomized trials, 6,582 adults, mean 12 weeks) — found that intermittent fasting strategies and continuous calorie restriction produce similarly small weight reductions versus an unrestricted diet, with no clinically important differences between most approaches. Alternate-day fasting was the only strategy with a modest edge over continuous calorie restriction (-1.29 kg), time-restricted eating (-1.69 kg) and 5:2/whole-day fasting (-1.05 kg); none of these between-method differences reached the 2 kg the authors set as minimally important, and certainty was low to moderate. For glycemic outcomes, a 2026 Diabetologia meta-analysis (Viple et al.; 10 RCTs, 599 adults with prediabetes or type 2 diabetes) found time-restricted eating lowered fasting blood glucose by 0.30 mmol/l overall (95% CI -0.53 to -0.07; moderate certainty), with the largest reduction in type 2 diabetes (-0.48 mmol/l) and a smaller one in prediabetes (-0.14 mmol/l); HbA1c fell significantly only in prediabetes, and body weight fell by 1.6 kg. Bottom line: intermittent fasting is a legitimate, evidence-based tool for modest weight loss and glycemic improvement — comparable to, not superior to, conventional calorie restriction — and the metabolic benefit appears largest in those with the most dysglycemia. Educational information, not medical advice.
Evidence Scale
Mechanism of Action
Fasting depletes glycogen, shifting to ketone metabolism. Activates AMPK, inhibits mTOR, enhances autophagy, improves insulin sensitivity, and may extend lifespan.
Who Is This For?
Metabolic optimization, weight management, longevity. Not for eating disorders, underweight, or pregnancy.
Protocol & Dosing
Dose
16:8 most common and sustainable. Eating window typically 8-12 hours.
Frequency
Daily or alternating
Duration
Ongoing lifestyle
Protocol Summary
Various protocols: 16:8 (16 hours fasting), 5:2 (two low-calorie days), OMAD (one meal). Gradual adaptation recommended.
Latest Evidence
2025–2026: comparable to calorie restriction, with real metabolic benefit
The largest human synthesis to date — a BMJ 2025 systematic review and network meta-analysis (Semnani-Azad et al., 99 randomized trials, 6,582 adults) — found that intermittent fasting and continuous calorie restriction produce similarly small weight reductions versus an unrestricted diet. Alternate-day fasting was the only approach with a modest edge over continuous calorie restriction (−1.29 kg), time-restricted eating (−1.69 kg) and 5:2 fasting (−1.05 kg), but none of these between-method differences reached the 2 kg the authors set as minimally important, and certainty was low to moderate. The practical message: the best fasting protocol is the one a person will sustain.
For glucose, a 2026 Diabetologia meta-analysis (Viple et al., 10 RCTs, 599 adults with prediabetes or type 2 diabetes) found time-restricted eating lowered fasting blood glucose by 0.30 mmol/L overall, with the largest effect in type 2 diabetes (−0.48 mmol/L) and HbA1c improving significantly in prediabetes. Mechanistic longevity work continues in parallel: a 2026 Cell study showed caloric restriction reduced genome-wide somatic mutation burden in mice — a promising aging signal, though mouse caloric restriction is not the same as human 16:8 eating. Not advised in eating disorders, pregnancy, underweight, or type 1 diabetes. Educational information, not medical advice.
Meta-analysis · 10 RCTs · n=599 · fasting blood glucose
Time-restricted eating lowers fasting glucose most where dysglycemia is greatest
Source: Viple et al., "Effects of time-restricted eating on markers of glucose metabolism and regulation in individuals with prediabetes or type 2 diabetes," Diabetologia (2026) — 10 randomized trials, 599 participants. Bars show the pooled weighted mean difference in fasting blood glucose versus a non-time-restricted control (negative = reduction); 95% CIs in tooltip. The overall and type 2 diabetes estimates were statistically significant (moderate certainty). Educational information, not proof of causation for any individual.
Related on Peak Human
Weight Loss
Fasting as one sustainable lever for modest weight loss.
Diabetes
Glycemic benefit is largest where dysglycemia is greatest.
Longevity
Physician-guided healthy-aging protocols.
Advanced Testing
Fasting glucose and metabolic biomarker panels.
Continuous Glucose Monitor
See how your eating window moves glucose in real time.
Ketogenic Diet
A complementary metabolic dietary protocol.
Fasting Insulin Test
What a fasting insulin result can tell you about metabolic health.
Key references: Intermittent fasting strategies & cardiometabolic risk — network meta-analysis, BMJ (2025) · Time-restricted eating & glucose metabolism in prediabetes / type 2 diabetes — meta-analysis, Diabetologia (2026) · Caloric restriction & genome-wide somatic mutation — Cell (2026)
Interactions & Precautions
Contraindications
- Eating disorders
- Underweight
- Pregnancy/nursing
- Type 1 diabetes
- Advanced adrenal dysfunction
Potential Risks
- •Muscle loss if protein inadequate
- •Hormonal disruption in some women
- •Social challenges
Potential Side Effects
Practitioner Notes
Clinical annotations from Dr. Goel
Women may need modified approach (12-14 hour fast). Prioritize protein during eating window. Break fast gently. Consider fasting glucose and ketone monitoring. Updated August 2026: Of all nutritional strategies reviewed in the 2026 human senescence systematic review, calorie restriction had the most consistent effect on SASP-related and transcriptomic senescence markers - a useful, evidence-grounded point when patients ask which dietary lever matters most. Be precise that this reflects the secretory/inflammatory environment, not senescent-cell clearance. Updated September 13, 2026: The Cell 2026 somatic-mutation result is a useful mechanistic point when patients ask why restriction protocols might matter beyond weight and glucose — but be explicit that it is mouse caloric restriction, not 16:8 eating windows, and that somatic mutation burden is not measurable in clinic. Continue to anchor human recommendations on metabolic endpoints, body composition and adherence rather than on genomic-integrity claims. Updated November 3, 2026: Frame intermittent fasting to patients as roughly equivalent to continuous calorie restriction for weight (BMJ 2025 network meta-analysis), so the best protocol is the one a patient will adhere to; alternate-day fasting showed only a small, sub-threshold edge. Time-restricted eating is a reasonable adjunct for glycemic control, with the clearest fasting-glucose benefit in type 2 diabetes and HbA1c benefit in prediabetes (Diabetologia 2026). Continue to prioritize adequate protein and resistance training to protect muscle mass, individualize eating windows for women, and avoid in eating disorders, pregnancy and type 1 diabetes.
Dr. Sanjeev Goel
Chief Medical Officer, Peak Human
Cost & Access
Cost Range
Free
Accessibility
Availability varies by location
Sample member
Longevity Operator
One number for your longevity journey.
FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.
- Metabolic
- Hormonal
- Cardiovascular
- Brain / Cognitive
- Sleep
- Musculoskeletal
- Gut
- Immunity / Inflammation
